Literature DB >> 23648380

Low papillary structure in lepidic growth component of lung adenocarcinoma: a unique histologic hallmark of aggressive behavior.

Toshinori Fukutomi1, Yuichiro Hayashi, Katsura Emoto, Kazunori Kamiya, Mitsutomo Kohno, Michiie Sakamoto.   

Abstract

Small-sized lung adenocarcinomas often contain a lepidic growth component in part. The term lepidic growth has recently been used to represent a growth pattern of neoplastic cells along preexisting alveolar structures. We reviewed 91 small-sized (≤3 cm) invasive lung adenocarcinomas with a lepidic component to study the histopathologic and clinicopathologic characteristics. In the lepidic component of invasive adenocarcinoma, we have identified a morphologically unique structure characterized by proliferation of low papillae, consisting of neoplastic cells piling up toward the alveolar space, and we defined this architecture as "low papillary structure." There were 18 cases with the low papillary structure in the lepidic components, whereas 73 cases did not have the structure. In the lepidic component, the cases with the low papillary structure had higher Ki-67 labeling index (15.7%) and more frequent p53 overexpression (50.0%) than did those without the structure (9.4% and 16.4%, respectively). Based on clinicopathologic findings, the presence of low papillary structure was significantly associated with lymphatic invasion (P = .023) and lymph node metastasis (P = .001). Furthermore, the patients with the low papillary structure in the lepidic components demonstrated significantly shorter disease-free and overall survival than did those without the structure (P = .001 and P = .010, respectively). We conclude that the low papillary structure is a significant histologic feature in a lepidic component and is associated with aggressive cancer behavior in lung adenocarcinoma.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; Lepidic growth; Low papillary; Lung adenocarcinoma; Prognosis; Tumor invasion

Mesh:

Substances:

Year:  2013        PMID: 23648380     DOI: 10.1016/j.humpath.2013.02.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.

Authors:  Mai Matsumura; Koji Okudela; Yoko Kojima; Shigeaki Umeda; Yoko Tateishi; Akimasa Sekine; Hiromasa Arai; Tetsukan Woo; Michihiko Tajiri; Kenichi Ohashi
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

2.  Pulmonary miliary papillary/micropapillary adenocarcinoma manifesting as carcinomatous encephalitis.

Authors:  P Vaideeswar; S S Nayak; A Verma; N A Goel
Journal:  J Postgrad Med       Date:  2017 Jul-Sep       Impact factor: 1.476

3.  Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.

Authors:  Soohyun Hwang; Joungho Han; Misun Choi; Myung-Ju Ahn; Yong Soo Choi
Journal:  J Pathol Transl Med       Date:  2016-10-16

4.  Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.

Authors:  Mai Matsumura; Koji Okudela; Yu Nakashima; Hideaki Mitsui; Kaori Denda-Nagai; Takehisa Suzuki; Hiromasa Arai; Shigeaki Umeda; Yoko Tateishi; Chihiro Koike; Toshiaki Kataoka; Tatsuro Irimura; Kenichi Ohashi
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

5.  Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.

Authors:  Katsura Emoto; Takashi Eguchi; Kay See Tan; Yusuke Takahashi; Rania G Aly; Natasha Rekhtman; William D Travis; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2019-07-25       Impact factor: 15.609

6.  Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute.

Authors:  Ping Yuan; Jin Lin Cao; Azmat Rustam; Chong Zhang; Xiao Shuai Yuan; Fei Chao Bao; Wang Lv; Jian Hu
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

7.  Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer.

Authors:  Dong Soo Lee; Yeon Sil Kim; Chul Seung Kay; Sung Hwan Kim; Chang Dong Yeo; Jin Woo Kim; Seung Joon Kim; Young Kyoon Kim; Yoon Ho Ko; Jin Hyoung Kang; Kyo Young Lee
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.